---
title: "ANKE BIO: Exclusive agent product recombinant follicle-stimulating hormone-CTP fusion protein injection approved for market launch"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254418686.md"
description: "ANKE BIO announced that the recombinant human follicle-stimulating hormone-CTP fusion protein injection, exclusively represented by Suzhou Shengji Pharmaceutical Co., Ltd. in mainland China and Hong Kong, Macau, and Taiwan, has been approved for marketing by the National Medical Products Administration. This product is the first long-acting recombinant human follicle-stimulating hormone approved in China"
datetime: "2025-08-25T10:45:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254418686.md)
  - [en](https://longbridge.com/en/news/254418686.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254418686.md)
generator: "portal-rs"
---

# ANKE BIO: Exclusive agent product recombinant follicle-stimulating hormone-CTP fusion protein injection approved for market launch

ANKE BIO announced that the product recombinant human follicle-stimulating hormone-CTP fusion protein injection, exclusively represented by Suzhou Shengji Pharmaceutical Co., Ltd. in mainland China and Hong Kong, Macau, and Taiwan, has been approved for marketing by the National Medical Products Administration. This product is the first long-acting recombinant human follicle-stimulating hormone approved in China

### Related Stocks

- [300009.CN](https://longbridge.com/en/quote/300009.CN.md)

## Related News & Research

- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [Rapala VMC: Strong H1 sales and profit growth led to upgraded full-year outlook amid ongoing trade risks](https://longbridge.com/en/news/296480810.md)
- [DIMRI: H1 2026 net profit rose to ₪495.6M on revenue of ₪780.5M, with robust liquidity and equity](https://longbridge.com/en/news/296448412.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**